TELA Bio (TELA) Assets (QoQ) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | TELA Bio | 13.26 Mn | -26.28 Mn | 12.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.16% |
| Dec 31, 2025 | 32.20% |
| Sep 30, 2025 | -8.81% |
| Jun 30, 2025 | -12.57% |
| Mar 31, 2025 | -10.76% |
| Dec 31, 2024 | 63.29% |
| Sep 30, 2024 | -11.94% |
| Jun 30, 2024 | -16.19% |
| Mar 31, 2024 | -7.96% |
| Dec 31, 2023 | -10.62% |
| Sep 30, 2023 | -7.49% |
| Jun 30, 2023 | 60.55% |
| Mar 31, 2023 | -13.36% |
| Dec 31, 2022 | -14.72% |
| Sep 30, 2022 | 54.99% |
| Jun 30, 2022 | -7.27% |
| Mar 31, 2022 | -11.49% |
| Dec 31, 2021 | -9.10% |
| Sep 30, 2021 | -6.76% |
| Jun 30, 2021 | -5.77% |
| Mar 31, 2021 | -9.41% |
| Dec 31, 2020 | -6.38% |
| Sep 30, 2020 | -5.33% |
| Jun 30, 2020 | 65.79% |
| Mar 31, 2020 | -13.37% |
| Dec 31, 2019 | 194.67% |